AGTR1 and hypertensive disorder: Of 258 participants with hypertension, 143 were on antihypertensive drug treatment with β-blockers (n = 79 [55.2%]), inhibitors of the renin-angiotensin system (angiotensin-converting enzyme inhibitors or angiotensin II type-1 receptor blockers; n = 53 [37.1%]), vasodilators (calcium-channel blockers or α-blockers; n = 37 [25.9%]) or diuretics (n = 54 [37.8%]), prescribed in varying combinations in 63 (44.0%) patients.